Macquarie Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.22M | Sell |
145,654
-5,637
| -4% | -$306K | 0.03% | 366 |
|
|
2026
Q1 | $9.49M | Sell |
151,291
-79,665
| -34% | -$6.37M | 0.06% | 249 |
|
|
2025
Q4 | $22M | Sell |
230,956
-1,705,036
| -88% | -$167M | 0.1% | 168 |
|
|
2025
Q3 | $189M | Sell |
1,935,992
-9,213
| -0.5% | -$954K | 0.22% | 71 |
|
|
2025
Q2 | $209M | Sell |
1,945,205
-61,537
| -3% | -$6.23M | 0.26% | 62 |
|
|
2025
Q1 | $202M | Buy |
2,006,742
+83,337
| +4% | +$8.39M | 0.25% | 83 |
|
|
2024
Q4 | $167M | Buy |
1,923,405
+74,032
| +4% | +$6.52M | 0.2% | 114 |
|
|
2024
Q3 | $155M | Sell |
1,849,373
-11,026
| -0.6% | -$869K | 0.17% | 154 |
|
|
2024
Q2 | $143M | Buy |
1,860,399
+1,057,783
| +132% | +$77.4M | 0.16% | 160 |
|
|
2024
Q1 | $55M | Sell |
802,616
-91,132
| -10% | -$5.86M | 0.06% | 404 |
|
|
2023
Q4 | $51.7M | Sell |
893,748
-20,981
| -2% | -$1.12M | 0.06% | 422 |
|
|
2023
Q3 | $48.3M | Sell |
914,729
-24,508
| -3% | -$1.29M | 0.06% | 417 |
|
|
2023
Q2 | $50.8M | Sell |
939,237
-197,532
| -17% | -$10.3M | 0.06% | 425 |
|
|
2023
Q1 | $56.9M | Sell |
1,136,769
-12,391
| -1% | -$584K | 0.07% | 378 |
|
|
2022
Q4 | $53.2M | Buy |
1,149,160
+98,150
| +9% | +$4.25M | 0.06% | 423 |
|
|
2022
Q3 | $40.7M | Buy |
1,051,010
+13,597
| +1% | +$545K | 0.05% | 490 |
|
|
2022
Q2 | $38.7M | Buy |
1,037,413
+364,657
| +54% | +$14.8M | 0.04% | 550 |
|
|
2022
Q1 | $29.8K | Buy |
672,756
+17,002
| +3% | +$737K | 0.02% | 662 |
|
|
2021
Q4 | $27.9M | Sell |
655,754
-4,560
| -0.7% | -$192K | 0.02% | 671 |
|
|
2021
Q3 | $28.7M | Sell |
660,314
-433
| -0.1% | -$19.2K | 0.02% | 665 |
|
|
2021
Q2 | $28.3M | Buy |
660,747
+5,879
| +0.9% | +$247K | 0.02% | 689 |
|
|
2021
Q1 | $25.3M | Buy |
654,868
+6,056
| +0.9% | +$229K | 0.04% | 482 |
|
|
2020
Q4 | $23.3M | Buy |
648,812
+57,567
| +10% | +$2.07M | 0.03% | 478 |
|
|
2020
Q3 | $22.6M | Buy |
591,245
+8,461
| +1% | +$326K | 0.04% | 441 |
|
|
2020
Q2 | $20.5M | Buy |
582,784
+23,172
| +4% | +$834K | 0.04% | 458 |
|
|
2020
Q1 | $18.3M | Buy |
559,612
+147,355
| +36% | +$5.76M | 0.04% | 436 |
|
|
2019
Q4 | $18.6M | Sell |
412,257
-131,159
| -24% | -$5.49M | 0.03% | 533 |
|
|
2019
Q3 | $22.1M | Buy |
543,416
+91
| +0% | +$3.85K | 0.04% | 428 |
|
|
2019
Q2 | $23.4M | Buy |
543,325
+133,995
| +33% | +$5.15M | 0.04% | 426 |
|
|
2019
Q1 | $15.7M | Buy |
409,330
+12,130
| +3% | +$463K | 0.03% | 525 |
|
|
2018
Q4 | $14M | Sell |
397,200
-94,500
| -19% | -$3.43M | 0.03% | 519 |
|
|
2018
Q3 | $18.9M | Sell |
491,700
-30,800
| -6% | -$1.08M | 0.03% | 494 |
|
|
2018
Q2 | $17.1M | Hold |
522,500
| – | – | 0.03% | 510 |
|
|
2018
Q1 | $14.3M | Hold |
522,500
| – | – | 0.03% | 536 |
|
|
2017
Q4 | $12.7M | Sell |
522,500
-228,964
| -30% | -$6.32M | 0.02% | 583 |
|
|
2017
Q3 | $21.9M | Buy |
751,464
+54,999
| +8% | +$1.52M | 0.04% | 431 |
|
|
2017
Q2 | $19.3M | Sell |
696,465
-7,191
| -1% | -$191K | 0.04% | 455 |
|
|
2017
Q1 | $17.5M | Sell |
703,656
-6,556
| -0.9% | -$159K | 0.03% | 483 |
|
|
2016
Q4 | $15.4M | Sell |
710,212
-37,222
| -5% | -$812K | 0.03% | 511 |
|
|
2016
Q3 | $17.8M | Sell |
747,434
-644,956
| -46% | -$15.4M | 0.03% | 456 |
|
|
2016
Q2 | $32.5M | Buy |
1,392,390
+470,745
| +51% | +$10.2M | 0.03% | 433 |
|
|
2016
Q1 | $17.3M | Buy |
921,645
+199,450
| +28% | +$3.5M | 0.03% | 396 |
|
|
2015
Q4 | $13.3M | Hold |
722,195
| – | – | 0.03% | 465 |
|
|
2015
Q3 | $11.9M | Sell |
722,195
-270,000
| -27% | -$4.62M | 0.03% | 473 |
|
|
2015
Q2 | $17.6M | Hold |
992,195
| – | – | 0.03% | 391 |
|
|
2015
Q1 | $17.6M | Buy |
992,195
+2,700
| +0.3% | +$42.7K | 0.03% | 406 |
|
|
2014
Q4 | $13.1M | Sell |
989,495
-147,700
| -13% | -$1.89M | 0.03% | 462 |
|
|
2014
Q3 | $13.4M | Buy |
1,137,195
+50,000
| +5% | +$630K | 0.03% | 448 |
|
|
2014
Q2 | $13.9M | Buy |
1,087,195
+345,800
| +47% | +$4.5M | 0.03% | 437 |
|
|
2014
Q1 | $10M | Buy |
741,395
+100,000
| +16% | +$1.31M | 0.02% | 501 |
|
|
2013
Q4 | $7.71M | Sell |
641,395
-130,600
| -17% | -$1.54M | 0.01% | 533 |
|
|
2013
Q3 | $9.06M | Hold |
771,995
| – | – | 0.02% | 479 |
|
|
2013
Q2 | $7.16M | Buy |
+771,995
| New | +$6.55M | 0.02% | 513 |
|
Other funds holding BSX
Macquarie Group's BSX Position: Q2 2026 in Review
Macquarie Group reduced its Boston Scientific (BSX) stake by 3.7% in Q2 2026, selling an estimated $306K and leaving 145,654 shares worth $6.22M. The position accounts for 0.03% of the portfolio, ranked #366.
Macquarie Group first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $209M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Macquarie Group held 145,654 shares of Boston Scientific worth $6.22M as of Q2 2026.
- Macquarie Group sold 5,637 Boston Scientific shares in Q2 2026, an estimated $306K.
- Boston Scientific made up 0.03% of Macquarie Group's portfolio in Q2 2026, its #366 holding.
- Macquarie Group first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Macquarie Group's Boston Scientific position peaked at $209M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.